Breaking News

Botox on the Block?

April 29, 2014

Allergan approaches J&J about a takeover.

Allergan, which owns Botox, has approached Sanofi and Johnson & Johnson and other companies to gauge their interest in acquiring the company.


The reported moves comes after larger rival Valeant Pharmaceuticals joined forces with activist investor Bill Ackman to make an unsolicited $46 billion bid for the Botox maker. Allegan has adopted a poison-pill defense in its efforts to fend off the Valeant takeover, which has prompted analysts at Stifel to downgrade the pharmaceutical company to hold from buy. Shares in Allergan rose 1.2% just after the open.

Related End-User Markets:

Related Raw Materials:

blog comments powered by Disqus
  • Silent Partners

    Silent Partners

    Christine Esposito, Associate Editor||August 1, 2016
    From research & development to logistics to confidentiality, savvy distributors help finished formulators achieve their goals

  • Sustainability is Omnipresent

    Sustainability is Omnipresent

    Christine Esposito , Associate Editor||July 1, 2016
    Industry stakeholders convene in New York City for Organic Monitor’s annual event

  • Perceived Perfection

    Perceived Perfection

    Christine Esposito, Associate Editor||July 1, 2016
    From primers to pressed powders, facial cosmetics help create the illusion of a flawless complexion.